iShares Neuroscience and Healthcare ETF IBRN
Set alert
As of Oct 30, 3:12 PM ET
- YTD
- +1.60%
- 1 year
- +9.17%
- Open
- 32.75
- Prev close
- 33.29
- Mkt cap
- 5.30M
- Vol
- 1.77K
- Avg vol
- 2.35K
- EPS
- 1.39
- P/E
- 23.63
- Div yield
- 0.00%
More statistics
- Low
- 32.75
- High
- 32.84
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 26.81
- 200-d avg
- 25.11
News
2 months ago zacks.com
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.
2 months ago benzinga.com
PTC Therapeutics Expands Rare Disease Portfolio with 'Unique Opportunity'
PTC Therapeutics plans to acquire Sangamo’s ST-920 Fabry disease program for $111 million upfront, with FDA filing expected in Q4 2026.
7 months ago benzinga.com
Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures
Xenon Pharmaceuticals shares surge after Phase 3 data show strong seizure reduction for azetukalner, with FDA filing planned for 2026.
4 years ago etftrends.com
These 10 ETFs Were Last Week's Top Performers: Oct 3, 2022
These were the best-performing ETFs for the week ending Sept. 30, 2022. NOTE: We've excluded funds that use leverage or make inverse bets on their underlying assets.
4 years ago zacks.com
4 Best ETF Areas of Last Week That Are Up At Least 5%
Wall Street was downbeat last week led by Apple after it dropped plans to boost production of its new iPhones.
4 years ago seekingalpha.com
Why Now Could Be The Time To Consider Neuroscience Investments
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in…